SEARCH

SEARCH BY CITATION

References

  • 1
    Cohen RD, Stein R, Hanauer SB. Intravenous cyclosporine in ulcerative colitis: A five-year experience. Am J Gastroenterol 1999; 94: 158792.
    Direct Link:
  • 2
    Burke JF, Pirsch JD, Ramos EL, Salomon DR, Stablein DM, Van Buren DH, West JC. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. N Engl J Med 1994; 331: 35863.
  • 3
    Solem CA, Loftus EV, Tremaine WJ, Sandborn WJ. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol 2004; 99: 97101.
    Direct Link:
  • 4
    Fishman SJ, Wylonis LJ, Glickman JD, Cook JJ, Warsaw DS, Fisher CA, Jorkasky DJ, Niewiarowski S, Addonizio VP. Cyclosporine A augments human platelet sensitivity to aggregating agents by increasing fibrinogen receptor availability. J Surg Res 1991; 51: 938.
  • 5
    Bombeli T, Müller M, Werner Straub P, Haeberli A. Cyclosporine-induced detachment of vascular endothelial cells initiates the extrinsic coagulation system in plasma and whole blood. J Lab Clin Med 1996; 127: 62134.
  • 6
    Vanrenterghem Y, Roels L, Lerut T, Gruwez J, Michielsen P, Gresele P, Deckmyn H, Colucci M, Arnout J, Vermylen J. Thromboembolic complications and haemostatic changes in cyclosporine-treated cadaveric kidney allograft recipients. Lancet 1985; 1: 9991002.
  • 7
    Ueda D, Suzuki K, Malyszko J, Pietraszek MH, Takada Y, Takada A, Kawabe K. Fibrinolysis and serotonin under cyclosporine A treatment in renal transplant recipients. Thromb Res 1994; 76: 97102.
  • 8
    Cohen H, Neild GH, Patel R, Mackie IJ, Machin SJ. Evidence for chronic platelet hyperaggregability and in vivo activation in cyclosporine-treated renal allograft recipients. Thromb Res 1988; 49: 91101.
  • 9
    Grip O, Svensson P, Lindgren S. Inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol 2000; 35: 61923.
  • 10
    Bernstein C, Blanchard J, Houston D, Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population based cohort study. Thromb Haemost 2001; 85: 4304.
  • 11
    Kao A, Dlugos D, Hunter JV, Mamula P, Thorarensen O. Anticoagulation therapy in cerebral sinovenous thrombosis and ulcerative colitis in children. J Child Neurol 2002; 17: 47982.
  • 12
    Ozdil S, Akyuz F, Pinarbasi B, Demir K, Karaca C, Boztas G, Kaymakoglu S, Mungan Z, Besisik F, Cakaloglu Y, Okten A. Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?). Hepato-Gastroenterology 2004; 51: 76870.
  • 13
    Murata S, Ishikawa N, Oshikawa S, Yamaga J, Ootsuka M, Date H, Kitani M, Inatsu H, Eto T. Cerebral sinus thrombosis associated with severe active ulcerative colitis. Intern Med 2004; 43: 4003.